| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/06/2008 | CA2685106A1 6-phenylpyrimidinones as pim modulators |
| 11/06/2008 | CA2685036A1 Pharmaceutical use of substituted amides |
| 11/06/2008 | CA2685029A1 Multi-ring compounds and uses thereof |
| 11/06/2008 | CA2685017A1 2-substituted indole derivatives as calcium channel blockers |
| 11/06/2008 | CA2684977A1 A method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant |
| 11/06/2008 | CA2684968A1 Compounds, compositions containing such compounds, and methods of treatment of cancer and autoimmune diseases using such compounds |
| 11/06/2008 | CA2684778A1 Methods and compounds for vitamin d therapy |
| 11/06/2008 | CA2684724A1 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 11/06/2008 | CA2684561A1 Neurite formation promoter |
| 11/06/2008 | CA2683887A1 Aminodihydrothiazine derivatives substituted with a cyclic group |
| 11/06/2008 | CA2683634A1 Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredientformulations that contain tolperisone |
| 11/06/2008 | CA2683514A1 Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
| 11/06/2008 | CA2683488A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation |
| 11/06/2008 | CA2683159A1 Isoquinolinone derivatives as nk3 antagonists |
| 11/06/2008 | CA2682519A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 11/06/2008 | CA2682508A1 Dual-acting antihypertensive agents |
| 11/06/2008 | CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 11/06/2008 | CA2682032A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 11/06/2008 | CA2676791A1 Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof |
| 11/06/2008 | CA2672737A1 Anti-viral compounds |
| 11/06/2008 | CA2672298A1 Fused pyridine compounds useful in the prophylaxis or treatment of viral infections |
| 11/06/2008 | CA2671849A1 Carboranylporphyrins and uses thereof |
| 11/06/2008 | CA2667195A1 Antimicrobial and antiviral compounds and methods for their use |
| 11/06/2008 | CA2667150A1 Novel lipid compounds |
| 11/05/2008 | EP1988397A1 Compositions and method for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 11/05/2008 | EP1988171A1 Substance fki-2342 and process for production thereof |
| 11/05/2008 | EP1988164A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor |
| 11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
| 11/05/2008 | EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 11/05/2008 | EP1988093A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors |
| 11/05/2008 | EP1988091A1 Tricyclic compounds |
| 11/05/2008 | EP1988090A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 11/05/2008 | EP1988089A1 Imatinib base, and imatinib mesylate and processes for preparation thereof |
| 11/05/2008 | EP1988088A1 Thiolactones |
| 11/05/2008 | EP1988087A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases |
| 11/05/2008 | EP1988083A1 Triazole derivative |
| 11/05/2008 | EP1988081A1 Binding inhibitor of sphingosine-1-phosphate |
| 11/05/2008 | EP1988078A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 11/05/2008 | EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 11/05/2008 | EP1988076A1 Amide derivative or salt thereof |
| 11/05/2008 | EP1988075A1 Pyrrole derivative or salt thereof |
| 11/05/2008 | EP1987844A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 11/05/2008 | EP1987837A1 Pharmaceutical composition for increasing insulin secretion from pancreatic ß-cells |
| 11/05/2008 | EP1987834A2 Substituted piperidines as therapeutic compounds |
| 11/05/2008 | EP1987833A1 Use of pharmacological compounds for the prevention or the treatment of acute tolerance to morphinics. |
| 11/05/2008 | EP1987832A1 Sustained-release tablet composition of pramipexole |
| 11/05/2008 | EP1987831A1 Compounds effecting glucokinase |
| 11/05/2008 | EP1987830A1 Stabilized pharmaceutical composition |
| 11/05/2008 | EP1987829A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke |
| 11/05/2008 | EP1987828A1 salts of perindopril and their use in the therapy of hypertension |
| 11/05/2008 | EP1987827A1 Novel pharmaceutical |
| 11/05/2008 | EP1987826A1 Medicine and functional food for controlling or relieving itching and inflammation |
| 11/05/2008 | EP1987825A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 11/05/2008 | EP1987824A1 Composition for normalizing blood pressure |
| 11/05/2008 | EP1987823A1 Condensation aerosol containing zaleplon for inhalation |
| 11/05/2008 | EP1987820A1 Slow release misoprostol for obstetric and/or gynaecological applications |
| 11/05/2008 | EP1987819A1 Injectable presentation type of flupirtin |
| 11/05/2008 | EP1987816A1 Adsorbate of a rasagiline salt with a water-soluble inactive ingredient |
| 11/05/2008 | EP1987815A1 Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
| 11/05/2008 | EP1987814A1 Mifepristone pharmaceutical compositions and their methods of preparation |
| 11/05/2008 | EP1987813A1 Injectable pharmaceutical formulation of taxoids in stable liposomes |
| 11/05/2008 | EP1987811A1 Skin-whitening cosmetic |
| 11/05/2008 | EP1987804A1 Implantable system for an intervertebral disc and intervertebral disc implant |
| 11/05/2008 | EP1987145A2 Rna interference mediated inhibition of hepatitis c virus |
| 11/05/2008 | EP1987051A2 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| 11/05/2008 | EP1987039A2 Melanin concentrating hormone receptor-1 antagonists |
| 11/05/2008 | EP1987038A2 Hcv ns5b inhibitors |
| 11/05/2008 | EP1987037A2 Fused heterocyclic compound |
| 11/05/2008 | EP1987036A1 Hetero-bycyclic antiviral compounds |
| 11/05/2008 | EP1987035A1 Heterocyclic antiviral compounds |
| 11/05/2008 | EP1987034A1 Spiro condensed piperidnes as modulators of muscarinic receptors |
| 11/05/2008 | EP1987033A1 Novel diazabicycloalkane derivatives and their medical use |
| 11/05/2008 | EP1987032A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists |
| 11/05/2008 | EP1987031A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
| 11/05/2008 | EP1987030A1 3 -deazapurine derivatives as tlr7 modulators |
| 11/05/2008 | EP1987029A1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands |
| 11/05/2008 | EP1987028A2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 11/05/2008 | EP1987026A1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 11/05/2008 | EP1987025A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 11/05/2008 | EP1987024A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 11/05/2008 | EP1987023A1 Hydrate forms of amg706 |
| 11/05/2008 | EP1987022A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives |
| 11/05/2008 | EP1987021A1 Substituted prolinamides, their preparation and their use as pharmaceuticals |
| 11/05/2008 | EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 11/05/2008 | EP1987019A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators |
| 11/05/2008 | EP1987017A1 Radioligands for the 5 -ht1b receptor |
| 11/05/2008 | EP1987013A1 Bicyclic sphingosine 1-phosphate analogs |
| 11/05/2008 | EP1987010A1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 11/05/2008 | EP1987009A1 Cyclourea compounds as calcium channel blockers |
| 11/05/2008 | EP1987007A1 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases |
| 11/05/2008 | EP1987006A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 11/05/2008 | EP1987005A2 New pyridin-3-amine derivatives |
| 11/05/2008 | EP1987004A2 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 11/05/2008 | EP1987003A1 Pyridine-2-carboxamide derivatives |
| 11/05/2008 | EP1987001A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 11/05/2008 | EP1986999A1 Benzoisoindole derivatives and their use as ep4 receptor ligands |
| 11/05/2008 | EP1986998A1 Metabotropic glutamate receptor-potentiating soindolones |
| 11/05/2008 | EP1986994A2 Novel crystalline forms of armodafinil and preparation thereof |
| 11/05/2008 | EP1986747A2 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 11/05/2008 | EP1986714A1 Coronary stent that releases medicamentuous composition to prevent and treat restenosis and fabrication process |